Siemens Healthineers Raises 2021 Forecast

The transcript discusses Siemens Healthineers' strong quarter performance, highlighting the role of antigen testing kits in their success. It addresses the expected decline in demand for these kits due to increased vaccinations and market saturation. The company anticipates a return to pre-pandemic levels in hospital operations, particularly in elective surgeries. Additionally, the transcript explores the global workforce's adaptation to virtual business practices, emphasizing the efficiency and opportunities they present.

How has the pandemic recovery impacted the core business in diagnostics?

What was the volume of antigen tests expected in the peak quarter?

What factors are contributing to the expected drop in demand for antigen testing kits?

What are the expectations for elective surgeries returning to normal levels?

What changes in hospital procedures have been observed post-pandemic?

What is the Siemens Healthineers' approach to staff vaccination policies?

How has the company adapted to virtual business operations during the pandemic?